{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:29:39Z","timestamp":1707179379426},"reference-count":31,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.205512","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T16:32:36Z","timestamp":1707150756000},"source":"Crossref","is-referenced-by-count":0,"title":["Construction of a necroptosis-related lncRNA signature for predicting prognosis and revealing the immune microenvironment in bladder cancer"],"prefix":"10.18632","author":[{"given":"Jingsong","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"},{"name":"Institute of Urologic Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"},{"name":"Institute of Urologic Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, People\u2019s Hospital of Hanchuan City, Xiaogan, Hubei 432300, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyuan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"},{"name":"Institute of Urologic Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Jian","sequence":"additional","affiliation":[{"name":"Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"},{"name":"Institute of Urologic Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"},{"name":"Institute of Urologic Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"},{"name":"Institute of Urologic Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"},{"name":"Institute of Urologic Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"},{"name":"Institute of Urologic Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2024,2,5]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer.","volume":"6","author":"Lotan","year":"2013","journal-title":"Eur Urol"},{"key":"2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"7","author":"Bray","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020.","volume":"7","author":"Galsky","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).","volume":"8","author":"Roupr\u00eat","year":"2022","journal-title":"Eur Urol"},{"key":"5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","article-title":"Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective.","volume":"1","author":"Babjuk","year":"2022","journal-title":"Nat Rev Urol"},{"key":"6","doi-asserted-by":"publisher","first-page":"866","DOI":"10.6004\/jnccn.2022.0041","article-title":"NCCN Guidelines\u00ae Insights: Bladder Cancer, Version 2.2022.","volume":"2","author":"Herr","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2013.06.020","article-title":"lincRNAs: genomics, evolution, and mechanisms.","volume":"15","author":"Bartel","year":"2013","journal-title":"Cell"},{"key":"8","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1158\/0008-5472.CAN-19-0255","article-title":"Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma.","volume":"7","author":"Lee","year":"2019","journal-title":"Cancer Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41419-021-04296-1","article-title":"LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer.","volume":"1","author":"Zhu","year":"2021","journal-title":"Cell Death Dis"},{"key":"10","doi-asserted-by":"publisher","first-page":"146431","DOI":"10.1172\/JCI146431","article-title":"SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer.","volume":"13","author":"Lin","year":"2021","journal-title":"J Clin Invest"},{"key":"11","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.immuni.2023.05.017","article-title":"Sublethal necroptosis signaling promotes inflammation and liver cancer.","volume":"5","author":"Gallage","year":"2023","journal-title":"Immunity"},{"key":"12","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3389\/fphar.2018.00721","article-title":"The Role of Necroptosis in Cardiovascular Disease.","volume":"9","author":"Yue-Chun","year":"2018","journal-title":"Front Pharmacol"},{"key":"13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.trecan.2017.03.002","article-title":"Necroptosis and Cancer.","volume":"3","author":"Yuan","year":"2017","journal-title":"Trends Cancer"},{"key":"14","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1038\/s41467-021-23004-3","article-title":"ZBP1 not RIPK1 mediates tumor necroptosis in breast cancer.","volume":"1","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41419-022-05524-y","article-title":"TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1\/RIPK3\/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer.","volume":"1","author":"Zhu","year":"2023","journal-title":"Cell Death Dis"},{"key":"16","doi-asserted-by":"publisher","first-page":"106936","DOI":"10.1016\/j.ijsu.2022.106936","article-title":"Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery.","volume":"10","author":"Xie","year":"2022","journal-title":"Int J Surg"},{"key":"17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-019-1029-8","article-title":"The role of necroptosis in cancer biology and therapy.","volume":"1","author":"Liu","year":"2019","journal-title":"Mol Cancer"},{"key":"18","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1158\/0008-5472.CAN-08-4079","article-title":"The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma.","volume":"6","author":"Habib","year":"2009","journal-title":"Cancer Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1158\/0008-5472.CAN-09-0474","article-title":"RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN.","volume":"6","author":"Habib","year":"2009","journal-title":"Cancer Res"},{"key":"20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.4149\/neo_2015_071","article-title":"Receptor-interacting protein kinase 3 is a predictor of survival and plays a tumor suppressive role in colorectal cancer.","volume":"6","author":"Wang","year":"2015","journal-title":"Neoplasma"},{"key":"21","doi-asserted-by":"publisher","first-page":"103750","DOI":"10.1016\/j.ebiom.2021.103750","article-title":"Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II\/III colorectal cancer.","volume":"7","author":"Han","year":"2022","journal-title":"EBioMedicine"},{"key":"22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","article-title":"Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer.","volume":"1","author":"Han","year":"2022","journal-title":"Nat Commun"},{"key":"23","doi-asserted-by":"publisher","first-page":"7488188","DOI":"10.1155\/2021\/7488188","article-title":"m6A-Related lncRNA to Develop Prognostic Signature and Predict the Immune Landscape in Bladder Cancer.","volume":"202","author":"Huang","year":"2021","journal-title":"J Oncol"},{"key":"24","doi-asserted-by":"publisher","first-page":"107146","DOI":"10.1016\/j.intimp.2020.107146","article-title":"Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.","volume":"9","author":"Yang","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"25","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.18632\/aging.102225","article-title":"An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer.","volume":"1","author":"Huang","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"26","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1111\/cas.15537","article-title":"Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer.","volume":"11","author":"Li","year":"2022","journal-title":"Cancer Sci"},{"key":"27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ejca.2021.08.006","article-title":"Impact of intratumoural CD73 expression on prognosis and therapeutic response in patients with gastric cancer.","volume":"15","author":"Li","year":"2021","journal-title":"Eur J Cancer"},{"key":"28","doi-asserted-by":"publisher","first-page":"954039","DOI":"10.3389\/fimmu.2022.954039","article-title":"Intratumoral CD73: An immune checkpoint shaping an inhibitory tumor microenvironment and implicating poor prognosis in Chinese melanoma cohorts.","volume":"1","author":"Gu","year":"2022","journal-title":"Front Immunol"},{"key":"29","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment.","volume":"1","author":"Fu","year":"2013","journal-title":"Nat Immunol"},{"key":"30","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1097\/MJT.0000000000000934","article-title":"Immunotherapy in Bladder Cancer.","volume":"2","author":"Aronow","year":"2022","journal-title":"Am J Ther"},{"key":"31","doi-asserted-by":"publisher","first-page":"e000147","DOI":"10.1136\/jitc-2019-000147","article-title":"Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project.","volume":"8","author":"Cheng","year":"2020","journal-title":"J Immunother Cancer"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T16:32:40Z","timestamp":1707150760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,5]]},"references-count":31,"alternative-id":["205512"],"URL":"https:\/\/doi.org\/10.18632\/aging.205512","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,5]]}}}